Trial Profile
A Single-Dose, Open-Label, Pharmacokinetic Study Of Ulipristal Acetate In Healthy Subjects With Normal Renal Function And Patients With Moderately Or Severly Impaired Renal Function
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ulipristal (Primary)
- Indications Pregnancy; Uterine leiomyoma
- Focus Pharmacokinetics
- Sponsors Allergan; Forest Laboratories
- 18 Jan 2018 Status changed from recruiting to completed.
- 07 Sep 2016 Planned End Date changed from 1 Aug 2016 to 1 Oct 2016.
- 07 Sep 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Oct 2016.